ChromoCure, Inc. (KKUR)

ChromoCure Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2009	FY 2008	FY 2005	FY 2004	FY 2003
Period Ending	Dec 31, 2009	Dec 31, 2008	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003
Revenue	-	-	0.24	0.04	-
Revenue Growth (YoY)	-	-	471.36%	-	-
Cost of Revenue	-	-	0.03	-	-
Gross Profit	-	-	0.21	0.04	-
Selling, General & Admin	0.12	0.05	0.27	0.15	0.07
Research & Development	-	-	0.08	0.23	0.18
Operating Expenses	0.13	0.06	0.36	0.38	0.26
Operating Income	-0.13	-0.06	-0.15	-0.34	-0.26
Other Non Operating Income (Expenses)	-0.02	-	-	-	-
Pretax Income	-0.15	-0.06	-0.15	-0.34	-0.26
Net Income	-0.15	-0.06	-0.15	-0.34	-0.26
Net Income to Common	-0.15	-0.06	-0.15	-0.34	-0.26
Shares Outstanding (Basic)	1,609	452	1	0	0
Shares Outstanding (Diluted)	1,609	452	1	0	0
Shares Change (YoY)	255.98%	77209.74%	118.21%	15.35%	-
EPS (Basic)	-0.00	-0.00	-0.25	-1.26	-1.10
EPS (Diluted)	-0.00	-0.00	-0.25	-1.26	-1.10
Free Cash Flow	0.02	-0.05	-0.43	-0.34	-0.08
Free Cash Flow Per Share	-	-	-0.74	-1.28	-0.34
Gross Margin	-	-	88.76%	100.00%	-
Operating Margin	-	-	-61.62%	-813.03%	-
Profit Margin	-	-	-61.62%	-813.03%	-
Free Cash Flow Margin	-	-	-182.66%	-824.36%	-
EBITDA	-0.12	-0.05	-	-	-
D&A For EBITDA	0	0	-	-	-
EBIT	-0.13	-0.06	-0.15	-0.34	-0.26
EBIT Margin	-	-	-61.62%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.